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How Does a Vesicle Know It Is Full? Minireview
James Williams changes in quantal size at the NMJ have been incom-
pletely studied and most likely depend on the stimula-Molecular Neurobiology Laboratory
tion parameters used (Van der Kloot, 1991; Prior andThe Salk Institute
Tian, 1995).La Jolla, California 92037
Drugs that interfere with ACh metabolism can de-
crease the quantal size. L-(2)-vesamicol inhibits cholin-``Quanta'' is a term for the fundamental units of neuro-
ergic vesicle filling in a stereoselective manner. Origi-transmitter release at synapses. The term was used by
nally isolated based on its neuromuscular blockingKatz and colleagues to describe the spontaneous re-
activity, vesamicol is now known to be an allosteric,lease of neurotransmitter at the neuromuscular junction
noncompetitive inhibitor of the VAChT (Parsons et al.,(NMJ). Spontaneous quanta are related to evoked re-
1993). In experiments that will be described in detailsponses from nerve stimulation; evoked responses vary
below, prolonged stimulation in the presence of vesami-in a stepwise fashion corresponding to multiples of the
col leads to a decrease in quantal size. Another drugspontaneous quantal size (Fatt and Katz, 1952). Quanta
that interferes with ACh metabolism is hemicholinium-3are now equated with the exocytosis of the contents of
(HC-3), which blocks the activeuptake of precursor cho-a single vesicle of neurotransmitter, and in response to
line. HC-3 is similar to vesamicol in that it also decreasesnerve stimulation at the NMJ, 50±100 quanta are re-
quantal size with activity, but more prolonged periodsleased (Van der Kloot and Molgo, 1994).
of stimulation are needed (Van der Kloot, 1991).At the NMJ, an important determinant of quantal size
Other manipulations have been studied that increaseis theamount of acetylcholine (ACh) in a vesicle. Salpeter
quantal size (Van der Kloot, 1991). b-adrenergic stimula-and colleagues have proposed a ªsaturated diskº model
tion can increase quantal size, but there are specieswhere release of ACh from a single vesicle nearly satu-
differences; the effect is seen in frog but not mouse NMJrates the receptors within a disk-shaped area of z0.5
preparations. The production of larger quanta seems tomm diameter (Bartol et al., 1991). With an increase in
involve the VAChT as it is blocked by vesamicol. Also,the number of ACh molecules in a vesicle, the diameter
a cAMP-dependent signaling pathway may be involvedof the disk and thus quantal size increases. ACh is syn-
since epinephrine does not increase quantal size in thethesized in the cytoplasm, but it then must be loaded
presence of PKA inhibitors. Insulin also increases
into vesicles by an active transport mechanism since
quantal size in a vesamicol-sensitive manner at the frogthe ratio of vesicular to cytoplasmic ACh concentrations
NMJ, but it does not seem to depend on PKA. Theis estimated to be 100:1 (Parsons et al., 1993). Knowl-
increase in quantal size with insulin does not dependedge of the molecular mechanisms by which ACh is
on protein synthesis, so it is unlikely that there are
packaged into vesicles has increased greatly with the
changes in VAChT expression. Finally, the frog and mouse
recent cloning of the vesicular acetylcholine transporter
NMJ show increased quantal size after prolonged incu-
(VAChT). The VAChT is a proton±neurotransmitter anti-
bation with hypertonic solutions. The hypertonic effect
porter that uses a proton electrochemical gradient cre-
is blocked by both PKA inhibitors and vesamicol.
ated by V-type ATPases to fill cholinergic vesicles (Usdin Biochemical and Morphological Evidence for
et al., 1995). Different Cholinergic Vesicle Populations
There is increasing evidence that the filling of choliner- Cholinergic vesicles do not form a uniform population.
gic vesicles and thus the quantal size can be regulated There is biochemical, morphological, and functional evi-
at the NMJ. A number of manipulations can modify the dence for populations of vesicles that differ in amount
quantal size, and changes in the activity of the VAChT of neurotransmitter. These differences in vesicle filling
may be a source of this variability (Table 1). If the VAChT can lead to differences in quantal size.
is inhibited while the NMJ is stimulated, quantal size The electric organfrom the marine ray Torpedo is used
decreases until eventually there is no release (Cabeza to study differences between populations of preformed
and Collier, 1988; Searl et al., 1991). What if transport and recycling vesicles (reviewed by Prior and Tian,
activity is increased? That question is answered in a 1995). After stimulationof theelectric organ, two popula-
paper from the laboratory of Mu-ming Poo (Song et al., tions of cholinergic vesicles can be separated with den-
1997 [this issue of Neuron]) in which overexpression of sity-gradient centrifugation. The larger-sized popula-
the VAChT is shown to double quantal size. This result tion, termed VP1, contains more ACh and corresponds
from developing synapses argues against cholinergic to the preformed, full vesicles. Smaller vesicles, termed
vesicles being filled to a set point, but instead is evi- VP2, contain less ACh and are seen only after nerve
dence that the level of VAChT expression controls stimulation; they represent recycling vesicles that have
vesicular filling and thus quantal size. not yet completely filled with neurotransmitter. When
Quantal Size Can Be Modified electron microscopy is used to quantitate the vesicle
Quantal size can be both increased and decreased at sizes, VP2 vesicles are found to be 25% smaller in diam-
the NMJ (reviewed by Van der Kloot, 1991; Parsons et eter, which corresponds to a 58% decrease in volume.
al., 1993; Van der Kloot and Molgo, 1994). Perhaps the VP2 vesicles disappear if the preparation is rested after
most confusing results are changes in response to activ- stimulation. There are also metabolic differences in rates
ity; some studies find activity-dependent decreases in of ACh uptake between the two populations; VP2 vesi-
quantal size (Searl et al., 1990), but others find increases cles have a 4- to 7-fold higher ratio of ACh transport
activity to vesamicol receptor levels (Gracz et al., 1988).with activity (Lupa, 1988). However, activity-dependent
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Table 1. Manipulation of Quantal Size at the NMJ**
Decrease Quantal Size
· Mutation of conserved aspartate residues in (Song et al., 1997)
VAChT
· Inhibitors of VAChT (2)-Vesamicol, tetraphenylboron, dipicrylamine
· Inhibitors of active choline uptake Hemicholinium-3, troxypyrollium
· Weak bases and protonophores that disrupt Ammonia, nigericin
the proton gradient
· Activity (Searl et al., 1990)
Increase Quantal Size
· Overexpression of VAChT (Song et al., 1997)
· Epinephrine and cAMP derivatives Blocked by vesamicol and PKA inhibitors
Frog NMJ, but not mouse
· Insulin Blocked by vesamicol, but not PKA inhibitors
Frog NMJ, but not mouse
· Prolonged hypertonic solution Blocked by vesamicol and PKA inhibitors
· Activity (Lupa, 1988)
**(Van der Kloot, 1991; Parsons et al., 1993; Van der Kloot and Molgo, 1994).
The metabolic transport activity in both VP1 and VP2 Additional evidence for this interpretation is the finding
that production of the smaller quanta is inhibited byvesicles is blocked by vesamicol.
Vesamicol Predicts Functional Properties vesamicol. The snake is unique in showing this stimula-
tion-induced bimodality, so for further work in the rat,of the VAChT and Cholinergic Vesicles
Unfortunately, technical problems prevent electrophysi- vesamicol had to be used to uncover the two popula-
tions. With stimulation in nonsaturating concentrationsology measurements in Torpedo, but functional mea-
surements in other NMJ preparations show the same of vesamicol, there are two populations of quanta at
the rat NMJ (Searl et al., 1991). With saturating doses,distinction between preformed and recycling vesicles.
These functional studies have utilized vesamicol inhibi- uniform quantal size presumably results from complete
masking of the recycling population. Quantal size wastion of the VAChT to unmask the recycling population
of vesicles. not measured after prolonged stimulation in the pres-
ence of vesamicol, but the average response to nerveVesamicol has no effect in unstimulated preparations,
but prolonged nerve stimulation in the presence of vesa- stimulation was shown to decrease more than controls.
After stimulation in the presence of nonsaturating dosesmicol leads to a uniform decrease in quantal size (re-
viewed by Prior and Tian, 1995). At the NMJ, a change of vesamicol, it would be interesting to see if the quantal
size recovers with rest.in quantal size can result from either a change in the
amount of ACh in a vesicle or a change in the sensitivity Another line of evidence for multiple populations of
cholinergic vesicles is found with the cat superior cervi-of the postsynaptic receptors. In the presence of moder-
ate doses of vesamicol, no postsynaptic changes were cal ganglion (Cabeza and Collier, 1988). These experi-
ments did not measure quanta but instead studied thefound with application of the cholinergic agonist carba-
chol, so the decreased quantal size is most likely from release of ACh using perfused ganglia. With nerve stimu-
lation in the presence of vesamicol, release is inhib-a change in the amount of transmitter (Parsons et al.,
1993). This result is consistent with populations of both ited after z14% of initial tissue ACh is liberated. This
gives an estimate of the size of the preformed popula-preformed and recycling vesicles. Vesamicol has no ef-
fect on the preformed vesicles, but inhibits the filling of tion of cholinergic vesicles being z14% of tissue ACh
stores. Estimates of the size of preformed quanta havethe recycling vesicles. Without vesamicol, prolonged
10 Hz nerve stimulation can continue unabated, and also been made in terms of numbers of vesicles. The
estimates vary widely depending on the preparation:quantal size will actually be potentiated (Lupa, 1988).
However, in the presence of vesamicol, once the popula- z70,000 at rat NMJ; z700,000 at frog NMJ; and
z300,000 for snake NMJ (Prior and Tian, 1995). Whention of preformed vesicles is released, the quantal size
begins todecrease as incompletely filled, recycling vesi- HC-3 is used instead of vesamicol, z85% of initial tissue
ACh is released (Parsons et al., 1993). This is much dif-cles are released.
A pair of papers by Searl et al. (1990, 1991) provide ferent than the z14% release found with vesamicol, but
HC-3 is thought to inhibit release after depletion of bothfurther evidence for multiple populations of cholinergic
vesicles. In a snake NMJ preparation, prolonged nerve preformed vesicles and also cytoplasmic ACh stores.
Molecular Mechanism of Vesicle Loadingstimulation produces two populations of quanta (Searl
et al., 1990). One population is the same size as those The VAChT belongs toa family with four classes of trans-
porters that fill vesicles with neurotransmitter. Thefound before stimulation, but the second population is
decreased in size in a stimulation frequency-dependent classes include those for glutamate, GABA±glycine,
ACh, and monoamines. Mutants that are defective inmanner. Histograms of the quantal size are well fit by
two Gaussians, and the two populations are interpreted neuromuscular transmission led to the cloning of the
first VAChT from C. elegans, and homologs from Tor-as the normal-sized population of preformed vesicles
and a smaller-sized population of recycling vesicles. pedo, rat, and humans soon followed (reviewed by Usdin
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et al., 1995). ACh is transported in membranes from
PC12 cells stably expressing the human VAChT clone
(Varoqui and Erickson, 1996). Sequence analysis of
these transporters predicts a 12 transmembrane domain
topology with potential sites for N-glycosylation and
PKC phosphorylation. Conserved aspartate residues
are found in putative transmembrane domains I, VI, X,
and XI. The vesicular transporters are homologous to
bacterial multidrug resistance transporters but not to
the plasma membrane transport systems that remove
neurotransmitters from the synaptic cleft.
A ``cholinergic gene locus'' codes for the VAChT and
choline acetyltransferase. The gene for the VAChT is
contained within the first intron of choline acetyltransfer-
ase (references in Usdin et al., 1995). This gene structure
is conserved phylogenetically, and there is evidence for
coordinated expression. The relationship between the
two genes provides a convenient way for the neuron to
control two important determinants of vesicular loading:
cytoplasmic concentrations of ACh and vesicular trans-
port activity.
The next step is functional characterization of the
Figure 1. Models of Cholinergic Vesicle Fillingcloned VAChT; Song et al. use Xenopus embryos to
heterologously overexpress the rat VAChT in this first
results are consistent with the inhibition of both thefunctional study. Their successful overexpression of the
overexpressed rat VAChT and the endogenous XenopusVAChT may encourage others to try this approach with
VAChT but cannot be interpreted in the same way asother vesicular transporters or synaptic proteins. Inves-
the vesamicol experiments described above. The de-tigators could potentially fashion synapses emphasizing
crease in quantal size is seen in unstimulated synapses,whatever particular properties they are interested in
but vesamicol is added at the time of plating, so a popu-studying. For example, it would be very interesting to
lation of preformed vesicles may never form, or the pre-use the same method when the vesicular glutamate
formed vesicles may be already exhausted by the lowtransporter is cloned.
level, continuous spontaneous release. Nevertheless,Manipulation of the VAChT Changes Quantal Size
the results show that different-sized populations ofThe most striking finding of the paper by Song et al. is
quanta can be produced by modifying the activity of thethat quantal size can be doubled in immature NMJs by
VAChT.overexpression of the VAChT. Increased quantal size
In contrast to the results with overexpression of thecan develop even the absence of a postsynaptic target;
VAChT, the quantal size and frequency can be de-myocytes manipulated into contact with neurons record
creased by mutation of conserved aspartate residues.increased quantal size with a time course that is proba-
Mutation of the aspartate residue in transmembrane do-bly too fast to be accounted for by a postsynaptic effect.
main X of the VAChT leads to a significant decrease inFurther evidence against a postsynaptic mechanism is
quantal size and frequency. Surprisingly, mutation ofthat the rise and decay times of the response do not
the conserved aspartate decreases quantal size andchange when the amplitude is doubled, and that expres-
frequency below the endogenous level. The authorssion of the VAChT in the postsynaptic muscle is without
suggest that this may be due to oligomerization of theeffect. The simplest interpretation of the increase in
mutant protein with the endogenous Xenopus transport-quantal size is that there is now more neurotransmitter
ers or more likely from defects involving the proton gra-packaged in vesicles.
dient.Overexpression of the VAChT also trebles the fre-
How Does a Vesicle Know It Is Full?quency of spontaneous release. This is more difficult to
interpret than the increase in quantal size. One explana- Models of vesicle filling can be divided into two general
categories: steady state models or set point modelstion may be that more VAChTs cause maturation of the
synapse or synaptic vesicles. Another explanation may (Figure 1). The vesicle can be filled based on the steady
state between inflow and outflow, or the vesicle can fillbe that increased loading of ACh uncovers quantal re-
lease by increasing the signal to noise ratio. Before over- to a set point. At least at the immature NMJ, the results
of Song et al. (1997) support a steady state model.expression of the VAChT, a population of small vesicles
may be lost in the recording noise. VP1 vesicles from Torpedo demonstrate active uptake
of ACh, but the quantal size does not keep increasing.Song et al. use vesamicol to study the VAChT in their
developing NMJ culture system. They show that vesami- This implies that there is a leak mechanism that must
be accounted for by the model. However, studies withcol uniformly decreases the size and frequency of
quantal release. The size of quanta in the presence of radiolabeled ACh and false transmitters suggest that
the leak from preformed vesicles is relatively slow (Par-vesamicol is reduced so much that part of the decrease
in frequency may be explained by an inability to measure sons et al., 1993; Prior and Tian, 1995). The identity of
the leak mechanism is unknown.quantal release that is lost in the recording noise. The
Neuron
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A set point model would predict that with overexpres- Conclusion
Expression of the VAChT may provide a way to regulatesion of the VAChT, vesicles would fill more quickly, but
quantal size at the NMJ. By changing the area of post-that there would be no change in the amount of neuro-
synaptic membrane saturated with ACh (Bartol et al.,transmitter in a filled vesicle. A set point could becreated
1991), alteration in the amount of transmitter in a vesicleby a feedback mechanism, or if some component of the
is an important determinant of quantal size. The coordi-ACh packaging mechanism is limiting. The activity of the
nated expression of the VAChT and choline acetyltrans-V-type ATPases could create a set point, but previous
ferase offers a convenient way for the neuron to controlstudies have demonstrated that proton-motive force is
ACh metabolism, and the results of Song et al. shownot the limiting factor in ACh loading (Parsons et al.,
that direct manipulations of VAChT expression can1993). In addition, the results of Song et al. argue that
change the quantal size in immature NMJs. Labelingvesicles cannot be filling to a set point in developing
studies predict four VAChTs will be found on each vesi-NMJs. If there were a set point, then vesicles would fill
cle (Parsons et al., 1993), but increases or decreases infaster with more transporters, but quantal size would
this number could be used to modulate quantal size.not be doubled.
Furthermore, changes in the activity of the VAChT mayA steady state model would predict that overexpres-
account for shorter-term regulation of quantal size. Ap-sion of the VAChT would lead to an increase in the
plication of insulin leads to an increase in quantal sizeamount of neurotransmitter in the vesicle. Inflow can be
that is not sensitive to protein synthesis inhibitors, butmodeled as a function of the cytoplasmic concentration
which is sensitive to vesamicol. Similarly, metabolic dif-of ACh, and a rate constant that includes the activity of
ferences have been found between populations of cho-the VAChT, proton pump, and any other components.
linergic vesicles from Torpedo; VP2 vesicles have a 4- toAssuming that the cytoplasmic concentration is rela-
7-fold higher ratio of transport activity to vesamicol re-tively constant, then the inflow will be constant. The
ceptor levels.outflow can be modeled as a function of the vesicular
Mu-ming Poo and colleagues have found that imma-
ACh concentration and a rate constant representing the
ture NMJs have a skewed distribution of quantal sizes
leak mechanism. The leakwill increase as theconcentra-
dominated by small responses, but note that adult NMJ
tion of ACh rises inside the vesicle. A bathtub analogy
shows a Gaussian distribution of larger quantal sizes
can be a helpful way to think about the steady state
(Evers et al., 1989; Song et al., 1997). Previous studies
model. Let the faucet represent the inflow from the suggested that the skewed distribution in developing
VAChT, and let the drain represent the leak mechanism. synapses was largely the result of underdeveloped ACh
If the faucet and drain are open, then a steady state packaging (Evers et al., 1989). Although overexpression
level will be reached in the tub where the inflow from of the VAChT in developing NMJ cultures does not by
the faucet is balanced by the outflow from the drain. itself lead to a Gaussiandistribution of increased quantal
However, if the flow from the faucet is turned up (i.e., sizes, mean quantal size is increased. Regulation of
overexpression of the VAChT), then the bathtub will start VAChT expression may be a way for the neuron to con-
to fill. As the fluid level rises, the outflow from the drain trol quantal size during the development of mature syn-
will also increase until it balances the inflow, but now aptic transmission.
the steady state level will be higher than it was before
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